Pirbright scientists investigate the pig’s immune response to flu and identify specific cells which are important for fighting infection and for long term protection against influenza infection.
It is hoped the findings will shed more light on human response to flu and help the development of new vaccines.
Pigs are natural hosts for influenza and like humans, they can be infected by circulating strains and become unwell. Influenza viruses that infect pigs and humans are different, but some may have the potential to spread between both species, making them important zoonotic viruses.
The immune system in mammals has two different responses to infection, the innate immune response which is a rapid, non-specific response to infection, and the adaptive immune response which is much more specific and follows the innate response.
Scientists examined the adaptive immune response, particularly the CD8 T cell response. CD8 T cells are cells of the immune system that specifically target host cells that are infected with viruses and kill them to prevent the viruses spreading. T cells are important in the host’s immune response to disease and help prevent severe disease.
Published in Mucosal Immunology, this study is the first of its kind to define four different types of CD8 T cells: naïve, central memory, effector memory and differentiated effector porcine CD8 T cells, and focus carefully on the tissues where the cells are found. Results showed that the pig immune response differs from that seen in small animal models such as mice or ferrets, which are not natural hosts for influenza. This highlights the importance of using a natural host where possible in research to gain a more accurate understanding of the disease and to develop treatment and prevention solutions to improve animal health and welfare.
Researchers revealed both the location of CD8 T cells in different pig tissues and how they behave in response to infection. Previously it was thought that the number of T cells in the lungs declines rapidly after infection, however the research shows this is not the case, suggesting longer lasting protection against future infection.
Scientists also explored how CD8 T cells react in response to infection by examining differences in gene expression over time. Gene expression was found to be linked to the production of cytokines (chemicals to help the immune system fight infection) and production of different cells in the immune system, in particular tissue resident memory (TRM) cells. TRM cells do not circulate in the blood, but rather remain in tissues such as the lung, providing local protection from infection.
Responses to respiratory immunisation were also explored and demonstrated that nasal vaccination can result in high numbers of CD8 T cells in the airway but does not result in a whole-body immune response as would be seen with an injection directly into the muscle.
Dr Elma Tchilian, Head of the Mucosal Immunology group at Pirbright said: “These findings may prove to be crucial for the design of future vaccines against respiratory diseases. Tissue resident memory (TRM) cells are important in respiratory diseases such as influenza and COVID-19 and identifying, in detail, where they are located in a relevant animal model is important for our understanding of disease in pigs. This knowledge is also highly relevant to human disease. For the first time we describe the distribution of cells involved in the immune response and their activity over the course of natural infection or vaccination and these are important knowledge gaps to fill.”
For more information please contact firstname.lastname@example.org
Tel: +44 (0) 1483 231120.
Notes to Editors
The paper ‘Spatial, temporal and molecular dynamics of swine inﬂuenza virus-speciﬁc CD8 tissue resident memory T cells’ will be available in 'Mucosal Immunology' with the DOI/link https://doi.org/10.1038/s41385-021-00478-4
This research was funded by This work was supported by UK Research and Innovation Biotechnology and Biological Sciences Research Council, the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, the Townsend-Jeantet Prize Charitable Trust, and a Medical Research Council Grant.
About The Pirbright Institute
The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Based in the UK and receiving strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC) part of UK Research and Innovation (UKRI), the Institute works to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience.
The Institute is an independent company, limited by guarantee and a registered charity, governed by a Board of non-executive Trustee Directors.
With an annual income of £37 million from grants and commercial activity, and a total of £43.7 million strategic investment from BBSRC UKRI during 2021-2022, the Institute contributes to global food security and health, improving quality of life for animals and people.
For more information about The Pirbright Institute see: www.pirbright.ac.uk
The Biotechnology and Biological Sciences Research Council (BBSRC) is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by government, BBSRC invested £451 million in world-class bioscience in 2019-20. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
More information about BBSRC UKRI, its science and its impact: www.bbsrc.ukri.org
More information about BBSRC UKRI strategically funded institutes
You are receiving this content as we believe it will be in your interest. Should you no longer want to receive Pirbright press releases please reply with STOP or should you wish to know more about how we will use your data please refer to our Data Privacy Notice.